Drug recall
Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced
FDA recall event 86310 · Class II · OneBlood, Inc.
Key facts
| Event ID | 86310 |
|---|---|
| Recall numbers | B-0659-2020 |
| Recalling firm | OneBlood, Inc. |
| Product type | Biologics |
| Products | Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed. |
| Initiation date | Aug 7, 2020 |
| Report date | Sep 16, 2020 |
| Termination date | Sep 8, 2020 |
| City | Orlando |
| State | FL |
| Country | United States |
| FEI number | 1072425 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: